BP
Boobalan Pachaiyappan Roth Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
0.57%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $17 |
346%
upside
| 3 | -3.6% |
0
%
| 15 Oct ‘25 5 days ago |
|
|
|
Buy
Initiated
| $62 |
27%
upside
| 1 | +18% |
0
%
| 17 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $3 |
460%
upside
| 2 | -36% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $3 |
272%
upside
| 2 | -28% |
0
%
| 15 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $6 |
213%
upside
| 3 | +2.8% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $16 |
113%
upside
| 4 | +54% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $12 |
88%
upside
| 2 | -27% |
0
%
| 14 Jul ‘25 3 months ago |
|
|
|
Buy
Reiterated
| $116 | – | 2 | +58% |
0
%
| 18 Jun ‘25 4 months ago |
|
|
|
Buy
Maintained
| $9 |
181%
upside
| 2 | +4.6% |
0
%
| 18 Jun ‘25 4 months ago |
|
|
|
Buy
Initiated
| $29 |
364%
upside
| 1 | -69% |
0
%
| 5 Dec ‘24 10 months ago |
|